Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S5W-14868 · Session 5

Further to the answer to question S5W-05973 by Shona Robison on 31 January 2017, what assessment it has made of the effectiveness of the in…

Answered Asked by Miles Briggs Con Lodged 23 Feb 2018

The question

To ask the Scottish Government, further to the answer to question S5W-05973 by Shona Robison on 31 January 2017, what assessment it has made of the effectiveness of the initial funding provided in 2017-18 for insulin pumps and real-time continuous glucose monitoring.

The answer

Answered by Shona Robison on 7 Mar 2018 · 12 days after it was lodged, on time

The decision to invest further in CGM and insulin pumps was made on the basis of robust analysis of clinical evidence by NICE and SIGN. Effectiveness of these technologies is considered over the lifetime.
The Scottish Diabetes Survey enables us to track improvement over time against a range of important indicators including glycaemic control and the complications of diabetes. The Survey shows a developing trend of improvement in glycaemic control in the Scottish type 1 diabetes population over the wider period of investment in insulin pumps.
I would remind the Member that the decision to offer a CGM or insulin pump is a clinical one, and the results for the individual will be monitored by their clinical team. Where the expected outcomes are not being realised, clinicians will consider clinically appropriate changes to the care regime.

In the Official Report

No contribution in the Official Report cites S5W-14868 by reference.